Moderna's stock experienced a significant increase of over 10% in pre-market trading. According to Jin10, the company's first-quarter revenue surpassed market expectations, contributing to the stock's upward movement.
Article
Moderna's Stock Rises Over 10% Pre-Market as Q1 Revenue Exceeds Expectations
--・
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.